NEUVIOR®
Proper noun | NOO-VWAHR | /nuːˈvwɑː(r)/
NEU
Possibility and discovery;
callings from within.
VIOR
Virtuosity and passion;
the pursuit of excellence.
For everything medicine
has yet to become.
Ingenuity, and the
art of possibility.
A name for the work
we want to do.
NEUVIOR is a pharmaceutical research and technology company. We bring scientific imagination to the decisions, discoveries and resources that shape medicine.
Our name holds two ideas together. NEU is the willingness to discover: to notice a possibility, ask a better question and follow a calling from within. VIOR is the commitment to pursue it with skill and passion.
Neither is enough alone. Possibility needs disciplined work. Excellence needs a purpose worth the effort. That relationship shapes how we choose a programme, build a team and decide what deserves the next chapter.
Medicine is a human endeavour.
A medicines decision can begin with a line in a report. A new therapy can begin with a cell behaving differently. A cleaner production process can begin with a question about what we throw away.
Behind each is someone whose life, work or environment may eventually be affected. We care about the distance between an exciting idea and a useful change. Our work brings scientific investigation, engineering and commercial thinking into that distance.
We want people to understand what we are trying to change, why the question matters and how the work could progress. That is why our programme pages explain the problem as well as the ambition.
Three fields.
One instinct to move medicine forward.
Medicines Intelligence
Connect evidence with decisions and the work needed to deliver them. PHARMORIS sits here, alongside our developing pharmacy, implementation and value-review programmes.
Biomedical Research
Investigate the biology behind difficult diseases. Our initial focus is glioblastoma, including treatment-surviving cells, recurrence and the challenge of protecting normal brain function.
Resource Economics
Examine the resources behind medicine. ZYLON and PHARMORIS-ECO explore materials recovery, manufacturing choices and energy use with industrial practicality in view.
Light dispersion through a glass prism, photographed by Kelvinsong, CC0. Independent optical reference.
Company purpose
What turns a possibility into worthwhile work?
The name NEUVIOR holds discovery and disciplined excellence together. This view follows that relationship into programme choices: what attracts attention, what deserves examination and what could become useful. Select a lens to see how imagination, evidence and responsibility each change the question, without interrupting the definition above.
Editorial decision model, not measured NEUVIOR results. Sources identify the published context; selected lenses do not establish product performance, customer adoption or institutional endorsement.
Keep the question open long enough to learn.
Discovery benefits from attention to the unexpected, including findings that weaken an initial idea. This lens follows the observation and the challenge it deserves. A useful negative result can redirect a programme before a polished narrative turns it into a commitment.
Which observation deserves a different explanation?
Notice the possibility
A possibility begins as something worth looking at more closely. It may be a difficult medicines handover, an unexplained biological response or a discarded material. Curiosity gives the work its beginning, but does not establish the answer or its value.
- Give it a method
- Ask again
A clear observation or problem, separated from the explanation being proposed.
A useful next stepWrite the question without assuming its answer.
Possibility earns its next chapter through skilled work, challenge and a useful purpose.
Ambition supported by opportunity
Selected for Innovate UK support
Competitive public funding has supported defined NEUVIOR programmes. We are grateful for the opportunity to turn research proposals into development and feasibility work.
Awards and support
Glasgow | August 2025
A beginning built on initiative.
Varun Sharma founded NEUVIOR with a conviction that a young company could contribute to hard problems in medicine. Competitive selection through Innovate UK’s Growth Catalyst programme followed in the company’s earliest weeks.
Public support gave us the opportunity to develop PHARMORIS and pursue defined feasibility work. We are grateful to Innovate UK, Scottish Enterprise and the specialist contributors whose work has helped us advance.
The next task is to make that opportunity count. Software development, research design and completed initial ZYLON feasibility work give us specific questions to build on. Our ambition grows through what we learn and what we can make useful.
Our Founder.
Varun Sharma leads the connection between NEUVIOR’s scientific ambitions and the business being built to carry them forward.
His perspective begins with practical work, a willingness to enter unfamiliar fields and a belief that medicine deserves both imagination and persistence.
Read his story, the influences behind the company and the questions that continue to shape its direction.
Make room for what comes next.
NEUVIOR Constellation is our scientific destinations concept: places that could connect research, specialist workspaces, industry and public discovery. Scotland is one location under consideration; the long-term ambition reaches further.
The purpose is to help people and ideas move between disciplines without losing the practical support needed to develop them. A useful first location would teach us how to build the next.
Explore Constellation and the scientific, commercial and public value the concept aims to create.
The company behind the work.
NEUVIOR Pharmaceuticals Ltd is registered in Scotland, company number SC857853. Our registered office is Clyde Offices, 2nd Floor, 48 West George Street, Glasgow, G2 1BP.
For a scientific enquiry, potential collaboration or business conversation, tell us what you are working on and what a useful next step would look like.
